Regulatory Post-Marketing Surveillance Study for Brolucizumab
NCT04985487
·
clinicaltrials.gov ↗
RECRUITING
Status
3000
Enrollment
INDUSTRY
Sponsor class
Conditions
Neovascular Age-related Macular Degeneration
Interventions
OTHER:
brolucizumab
Sponsor
Novartis Pharmaceuticals